Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer
Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical benefit of the co-administration of
propranolol and etodolac (VT-122 therapy) in patients with clinically progressive prostate
cancer.